In the Press

Model-driven mitigation measures for reopening schools during the COVID-19 pandemic

As the COVID-19 pandemic drags on, we need strategies for reopening those schools that have remained closed. We developed stochastic network models to study the risks associated with returning to in-person learning during the COVID-19 pandemic, and to explore the value of mitigation measures in reducing these risks.


Report: COVID-19, lack of funding are hampering TB response

The COVID-19 pandemic continues to hamper efforts to diagnose and treat tuberculosis (TB), and international funding for the disease remains inadequate, according to new data from a TB research and advocacy group.


Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic

Question - What are the fitted filtration efficiencies (FFEs) of consumer-grade masks, improvised face coverings, and modified procedure masks commonly used during the coronavirus disease 2019 (COVID-19) pandemic?


Recommended composition of influenza virus vaccines for use in the 2022 southern hemisphere influenza season

Overview - It is recommended that quadrivalent vaccines for use in the 2022 southern hemisphere influenza season contain the following:


Differentiating migraine, cervicogenic headache and asymptomatic individuals based on physical examination findings: a systematic review and meta-analysis

Headache is one of the most prevalent and disabling conditions resulting in reduced quality of life and lower work productivity [1,2,3].


With positive data on mRNA Covid vaccine, Sanofi sets its sights on other pathogens

French vaccine giant Sanofi announced positive results of a Phase 1/2 clinical trial of its first mRNA vaccine on Tuesday, saying the early findings with a Covid-19 vaccine give the company confidence to shift gears on its mRNA program to pursue vaccines for other pathogens. The first in its sights is an influenza vaccine Sanofi hopes to begin testing in clinical trials next year.


Multi-faceted EPA Research Addressing Threats to Public Health from Wildfire Smoke

The U.S. Environmental Protection Agency’s (EPA’s) researchers are working to provide the science needed to better prepare and respond to outdoor and indoor wildfire smoke. The science is part of a large federal initiative by the Biden-Harris Administration outlined in a White House fact sheet to address the growing threat from wildfires, which are increasing in size and intensity, driven in large part by climate change.


Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis

This open pilot registry study aimed to evaluate and compare the prophylactic effects of Pycnogenol® or cranberry extract in subjects with previous, recurrent urinary tract infections (UTI) or interstitial cystitis (IC). Methods. Inclusion criteria were recurrent UTI or IC.


Quantifying impacts of the COVID-19 pandemic through life-expectancy losses: a population-level study of 29 countries

Losses in life expectancy were largely attributable to increased mortality above age 60 years and linked to official COVID-19 deaths.


Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening

Highlights - SASR-CoV-2 3CLpro shows cooperative unfolding in which dimers or tetramers predominate depending on the pH. SARS-CoV-2 3CLpro shows a pH-dependent hydrolytic activity that correlates with its structural stability.


none 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM 08:00 AM - 05:00 PM others https://g.page/r/CcoVFDGYiftXEAg/review https://www.facebook.com/Healthy-Builds-West-Palm-106299645058480/reviews/?ref=page_internal